Literature DB >> 2478491

Tenascin: a hexameric adhesive glycoprotein.

P G Natali1, L Zardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2478491     DOI： 10.1002/ijc.2910440718

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN： 0898-6924


× No keyword cloud information.
  13 in total

1.  The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.

Authors:  B Oz; F A Karayel; N L Gazio; F Ozlen; K Balci
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 2.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

3.  Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas.

Authors:  A Arista; C Sturiale; P Riva; V Tison; M Frattarelli; G Moscatelli; G Franceschi; A Spinelli
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  The human placenta: a model for tenascin expression.

Authors:  M Castellucci; I Classen-Linke; J Mühlhauser; P Kaufmann; L Zardi; R Chiquet-Ehrismann
Journal:  Histochemistry       Date:  1991

5.  Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.

Authors:  O Tiitta; T Wahlström; J Paavonen; A Linnala; S Sharma; V E Gould; I Virtanen
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

6.  Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.

Authors:  M Chilosi; M Lestani; A Benedetti; L Montagna; S Pedron; A Scarpa; F Menestrina; S Hirohashi; G Pizzolo; G Semenzato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Relationship between tenascin and alpha-smooth muscle actin expression in the developing human small intestinal mucosa.

Authors:  J F Beaulieu; S Jutras; J Durand; P H Vachon; N Perreault
Journal:  Anat Embryol (Berl)       Date:  1993-08

8.  The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay.

Authors:  M Lawniczak; J Sikora; P Kania; J Zeromski
Journal:  Lung       Date:  1992       Impact factor: 2.584

9.  Glioblastoma therapy by direct intralesional administration of I-131 radioiodine labeled antitenascin antibodies.

Authors:  P Riva; A Arista; C Sturiale; V Tison; S Lazzari; G Franceschi; A Spinelli; M Casi; G Sarti; F Campori
Journal:  Cell Biophys       Date:  1994

Review 10.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.